Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. - Wikidata - wikimedia - TriplyDB

Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.

Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.

http://www.wikidata.org/entity/Q33385700

about

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis Mycobacterium abscessus subsp abscessus lung disease: 'trouble ahead, trouble behind…'Highlight on advances in nontuberculous mycobacterial disease in North America.Identification and characterization of potential therapeutic candidates in emerging human pathogen Mycobacterium abscessus: a novel hierarchical in silico approach Rapid identification of M. abscessus and M. massiliense by MALDI-TOF mass spectrometry with a comparison to sequencing methods and antimicrobial susceptibility patterns.In vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system.Diagnosis of pulmonary tuberculosis and nontuberculous mycobacterial lung disease in Korea Mycobacterium abscessus Lung Disease in a Patient with Kartagener Syndrome.Infections in "noninfectious" lung diseases.Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients.Mycobacterium abscessus isolated from municipal water - a potential source of human infection.The genome sequence of 'Mycobacterium massiliense' strain CIP 108297 suggests the independent taxonomic status of the Mycobacterium abscessus complex at the subspecies level Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease.Differential diagnostic assays for discriminating mycobacteria, especially for nontuberculous mycobacteria: what does the future hold?Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.Principal component analysis of MALDI TOF MS mass spectra separates M. abscessus (sensu stricto) from M. massiliense isolates.Mycobacterium abscessus Complex Infections in Humans Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense.Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Mycobacterium abscessus-Induced Granuloma Formation Is Strictly Dependent on TNF Signaling and Neutrophil Trafficking.In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease.The significance of Mycobacterium abscessus subspecies abscessus isolation during Mycobacterium avium complex lung disease therapy.Impaired Expression of MAPK Is Associated with the Downregulation of TNF-α, IL-6, and IL-10 in Mycobacterium abscessus Lung Disease.Normalization of Elevated CA 19-9 Level after Treatment in a Patient with the Nodular Bronchiectatic Form of Mycobacterium abscessus Lung Disease.Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.Clofazimine Enteropathy: A Rare and Underrecognized Complication of Mycobacterial Therapy.Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies The First Korean Case of Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium abscessus Subspecies bolletii in a Patient with Bronchiectasis.Mycobacterium abscessus D-alanyl-D-alanine dipeptidase induces the maturation of dendritic cells and promotes Th1-biased immunity.Clinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung Disease Host immune response to rapidly growing mycobacteria, an emerging cause of chronic lung disease.Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease.

P2860

Q24187458-DA02CB98-1CEE-4648-97B6-A38319C96F20 Q24202353-9FF9C3EB-0FC6-43ED-A6D2-B0CA2EFDEACB Q26748674-CD368488-A0D0-4C54-BEEE-5EBBECD53F3D Q26775974-01F0E6C4-0D61-4547-9AA0-8113854CDC43 Q26822822-11EF2BA0-82B8-479A-B908-4E57ECBB63D5 Q27028191-BA170157-EE5C-4803-A80E-F5FDF222F190 Q28488335-4EB1BA71-3D70-4D25-AAA6-868D0B3DB27C Q31143061-1B1A1D9A-9ED5-4E81-B646-763FF27A6B77 Q33798263-F9B1F824-3A6C-430D-98A4-6EE27356D21F Q34022978-9C8C2E67-0306-44EA-BBF3-676C16A09D13 Q34316614-1A70D09C-63E8-43AC-AA54-E9A89B09B45B Q34357445-67FEBB67-6373-4245-979A-31631617F8A8 Q34373426-72AF508C-DEB5-48F8-90E9-B351068EC39D Q34528945-9ACA7FEB-3EFA-4654-83D7-EEDFBDBE130D Q34682886-56F2B677-688B-4C9F-B647-63814EFAA417 Q34738533-204ECEDC-4479-4D6F-A1EC-49241852D509 Q35060598-569BB7A1-8C9E-4451-B962-97210B551BE6 Q35127708-D8CD2560-CD7C-47B4-9B2C-26CA66A0B1DC Q35562770-6AA5E6CF-4A6C-4EAF-91D4-F56C9660057F Q35906474-FEF62845-6930-453A-A07E-8C1D40AE3AA5 Q35939699-489B7934-AFE6-4F42-BB48-89470D199886 Q35997500-D5DC52C0-DA8F-43BD-A851-6CFC0B18F302 Q36020330-03087BA4-4BC8-48E4-B856-4E7E6CFFEBAA Q36086312-A74BC610-9E0E-4403-AC88-51DB737D6566 Q36156072-1963E96D-B697-401C-9CC9-C81CF2E5E739 Q36180493-E771A84C-DE9C-4CE8-A4BE-44E70375D5FB Q36396162-FC70399B-6350-44B4-BC07-2EFB08742ADB Q36411157-46ADA28E-7E11-45F4-9655-24A644DAF770 Q36434273-DB7382F0-C6D5-4CDA-A928-8BAD0E1A667F Q37090049-E8C4F331-B7D5-4662-B4D3-12C0BAB5BF6B Q37287653-51967C9A-A663-4DE7-9281-9859C517CA97 Q37304358-817C0527-B166-4354-A437-C96588CCE1FF Q37375383-9AB70D2F-7975-4312-8C30-F17EAA483CB8 Q37481693-797F93E0-64D4-40A6-B08F-445A25373F14 Q37538786-07E24455-3FC2-4BCA-AA19-E252F081EF16 Q37575194-39E2B00A-0289-4E22-AE80-6DE164FBDCEF Q37581285-AC07A65A-8E08-4187-8C6C-DFCBD9BD40E1 Q37613058-65F2B4BE-8E2F-427F-B89C-2CAF702EC142 Q37676737-15D842E1-C69A-416A-B718-E78A36833D6B Q37679776-FF3FD157-EA86-460B-82CD-51C86530B223

P2860

Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.

http://www.wikidata.org/entity/Q33385700

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Antibiotic treatment of Mycoba ...... ctive analysis of 65 patients.

@ast

Antibiotic treatment of Mycoba ...... ctive analysis of 65 patients.

@en

type

label

Antibiotic treatment of Mycoba ...... ctive analysis of 65 patients.

@ast

Antibiotic treatment of Mycoba ...... ctive analysis of 65 patients.

@en

prefLabel

Antibiotic treatment of Mycoba ...... ctive analysis of 65 patients.

@ast

Antibiotic treatment of Mycoba ...... ctive analysis of 65 patients.

@en

P1433

Q33385700-A1F93A08-E15D-438C-B92E-8D30B96B2A9A

P1476

Q33385700-B7804C51-6C3C-4839-9D5A-91B769CC5BB0

P2093

Q33385700-2AD9FE83-027B-4408-B48C-BF544BB708D8

Q33385700-2D7AFDA7-607D-4B31-9F2E-CC48081D6ACD

Q33385700-3965AFDD-94E9-42C5-A4CA-D36A3C567642

Q33385700-44D9F86C-7C1F-48A0-B449-323AB497565D

Q33385700-519398CE-00C6-4A0B-821B-C69C52F56887

Q33385700-51BD8F3F-B47B-4CC2-8104-926CAC340611

Q33385700-5CE8AFC0-890F-4843-987B-2441D95C6958

Q33385700-6134A4A7-72E1-483F-9A62-AA454698BF78

Q33385700-A2218A37-9F2E-4428-9A7B-CDF4335A6816

P2860

Q33385700-033A485C-8ED2-4CDC-A518-629F72C4C198

Q33385700-0722B05A-39DA-43F7-A5E9-B6B51BBFEC7E

Q33385700-08606C28-BE5D-4695-B88F-9A3FA1CD4791

Q33385700-0EB893DD-C465-4DE5-8529-1D3D5C2C5959

Q33385700-1049C9EC-4331-4C73-9E6D-408E0AA489D6

Q33385700-14E8D166-4FE7-461F-85E9-F30C236CCAE3

Q33385700-17A3CBBD-DFB8-47E3-806E-0BDA0EC60660

Q33385700-23E052B4-7378-490C-A3EC-9B27B8AFFC1B

Q33385700-4239877E-E8C2-4F73-A4C4-90A33B296B0B

Q33385700-4B6ADDF4-8E2A-4DDE-A14D-4F26EEF0D0CD

P304

Q33385700-6167FFBB-F3C3-4BBF-8D0C-5843A5E58BB7

P31

Q33385700-250E04BB-5409-4CBF-8024-E004CBE8482C

P356

Q33385700-E99A4FE1-106A-42F7-B87E-C9DF784542BF

P407

Q33385700-A6650EC9-1B2B-46BD-B042-76B985616FF8

P433

Q33385700-19DAFD18-0435-42DA-A4E1-F3B25E38D3F4

P478

Q33385700-E353E0C1-E68A-4ED0-A74A-6DA8A754B17A

P577

Q33385700-FC324E61-71F2-4CA6-ADD3-3A0E3FB72217

P698

Q33385700-1FBED0B0-43FA-45B2-8691-1F0183F99A9F

P356

RCCM.200905-0704OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Antibiotic treatment of Mycoba ...... ctive analysis of 65 patients.

@en

P2093

Bum-Joon Kim

http://www.w3.org/2001/XMLSchema#string

Chang Ki Kim

http://www.w3.org/2001/XMLSchema#string

Kyeongman Jeon

http://www.w3.org/2001/XMLSchema#string

Nam Yong Lee

http://www.w3.org/2001/XMLSchema#string

O Jung Kwon

http://www.w3.org/2001/XMLSchema#string

Seung-Heon Lee

http://www.w3.org/2001/XMLSchema#string

Won-Jung Koh

http://www.w3.org/2001/XMLSchema#string

Yoon-Hoh Kook

http://www.w3.org/2001/XMLSchema#string

Young Kil Park

http://www.w3.org/2001/XMLSchema#string

P2860

Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov

rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov

Amoebal coculture of "Mycobacterium massiliense" sp. nov. from the sputum of a patient with hemoptoic pneumonia

Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This st

Activities of linezolid against rapidly growing mycobacteria.

Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.

A prospective study of neutropenia induced by high doses of beta-lactam antibiotics.

Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans.

Pulmonary disease caused by rapidly growing mycobacteria.

High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.

P304

896-902

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200905-0704OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19661243

http://www.w3.org/2001/XMLSchema#string